• Je něco špatně v tomto záznamu ?

Differential effects of the enantiomers of tamsulosin and tolterodine on P-glycoprotein and cytochrome P450 3A4

A. Doricakova, D. Theile, J. Weiss, R. Vrzal,

. 2017 ; 390 (1) : 49-59. [pub] 20160927

Jazyk angličtina Země Německo

Typ dokumentu srovnávací studie, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17013504
E-zdroje Online Plný text

NLK ProQuest Central od 2013-01-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 2000-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 2013-01-01 do Před 1 rokem

The pregnane X receptor (PXR) is a transcription factor regulating P-glycoprotein (P-gp; ABCB1)-mediated transport and cytochrome P450 3A4 (CYP3A4)-mediated metabolism of xenobiotics thereby affecting the pharmacokinetics of many drugs and potentially modulating clinical efficacy. Thus, pharmacokinetic drug-drug interactions can arise from PXR activation. Here, we examined whether the selective α1-adrenoreceptor blocker tamsulosin or the antagonist of muscarinic receptors tolterodine affect PXR-mediated regulation of CYP3A4 and of P-gp at the messenger RNA (mRNA) and protein level in an enantiomer-specific way. In addition, the effect of tamsulosin and tolterodine on P-gp activity was evaluated. We used quantitative real-time PCR, gene reporter assay, western blotting, rhodamine efflux assay, and calcein assay for determination of expression, activity, and inhibition of P-glycoprotein. The studied compounds significantly and concentration-dependently increased PXR activity in the ABCB1-driven luciferase-based reporter gene assay. We observed much stronger induction of ABCB1 mRNA by S-tamsulosin as compared to the R or racemic form. R or racemic form of tolterodine and R-tamsulosin concentration-dependently increased P-gp protein expression; the latter also enhanced P-gp efflux function in a rhodamine-based efflux assay. R-tamsulosin and all forms of tolderodine slightly inhibited P-gp. The effect on CYP3A4 expression followed the same pattern but was much weaker. Taken together, tamsulosin and tolterodine are demonstrated to interfere with P-gp and CYP3A4 regulation in an enantiomer-specific way.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17013504
003      
CZ-PrNML
005      
20170427103214.0
007      
ta
008      
170413s2017 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00210-016-1304-9 $2 doi
035    __
$a (PubMed)27678410
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Doricakova, Aneta $u Department of Cell Biology and Genetics, Faculty of Science, Palacky University, Slechtitelu 27, 783 71, Olomouc, Czech Republic.
245    10
$a Differential effects of the enantiomers of tamsulosin and tolterodine on P-glycoprotein and cytochrome P450 3A4 / $c A. Doricakova, D. Theile, J. Weiss, R. Vrzal,
520    9_
$a The pregnane X receptor (PXR) is a transcription factor regulating P-glycoprotein (P-gp; ABCB1)-mediated transport and cytochrome P450 3A4 (CYP3A4)-mediated metabolism of xenobiotics thereby affecting the pharmacokinetics of many drugs and potentially modulating clinical efficacy. Thus, pharmacokinetic drug-drug interactions can arise from PXR activation. Here, we examined whether the selective α1-adrenoreceptor blocker tamsulosin or the antagonist of muscarinic receptors tolterodine affect PXR-mediated regulation of CYP3A4 and of P-gp at the messenger RNA (mRNA) and protein level in an enantiomer-specific way. In addition, the effect of tamsulosin and tolterodine on P-gp activity was evaluated. We used quantitative real-time PCR, gene reporter assay, western blotting, rhodamine efflux assay, and calcein assay for determination of expression, activity, and inhibition of P-glycoprotein. The studied compounds significantly and concentration-dependently increased PXR activity in the ABCB1-driven luciferase-based reporter gene assay. We observed much stronger induction of ABCB1 mRNA by S-tamsulosin as compared to the R or racemic form. R or racemic form of tolterodine and R-tamsulosin concentration-dependently increased P-gp protein expression; the latter also enhanced P-gp efflux function in a rhodamine-based efflux assay. R-tamsulosin and all forms of tolderodine slightly inhibited P-gp. The effect on CYP3A4 expression followed the same pattern but was much weaker. Taken together, tamsulosin and tolterodine are demonstrated to interfere with P-gp and CYP3A4 regulation in an enantiomer-specific way.
650    _2
$a zvířata $7 D000818
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a cytochrom P-450 CYP3A $x genetika $x metabolismus $7 D051544
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a regulace genové exprese enzymů $x účinky léků $7 D015971
650    _2
$a lidé $7 D006801
650    _2
$a isomerie $7 D007536
650    _2
$a LLC-PK1 buňky $7 D018374
650    _2
$a myši $7 D051379
650    _2
$a P-glykoproteiny $x antagonisté a inhibitory $x genetika $x metabolismus $7 D018435
650    _2
$a promotorové oblasti (genetika) $7 D011401
650    _2
$a messenger RNA $x genetika $x metabolismus $7 D012333
650    _2
$a steroidní receptory $x agonisté $x metabolismus $7 D011987
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
650    _2
$a sulfonamidy $x chemie $x farmakologie $7 D013449
650    _2
$a prasata $7 D013552
650    _2
$a tolterodin tartarát $x chemie $x farmakologie $7 D000068737
650    _2
$a transfekce $7 D014162
650    _2
$a upregulace $7 D015854
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
700    1_
$a Theile, Dirk $u Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
700    1_
$a Weiss, Johanna $u Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
700    1_
$a Vrzal, Radim $u Department of Cell Biology and Genetics, Faculty of Science, Palacky University, Slechtitelu 27, 783 71, Olomouc, Czech Republic. radim.vrzal@email.cz.
773    0_
$w MED00003462 $t Naunyn-Schmiedeberg's archives of pharmacology $x 1432-1912 $g Roč. 390, č. 1 (2017), s. 49-59
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27678410 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20170427103534 $b ABA008
999    __
$a ok $b bmc $g 1199969 $s 974282
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 390 $c 1 $d 49-59 $e 20160927 $i 1432-1912 $m Naunyn-Schmiedeberg's archives of pharmacology $n Naunyn Schmiedebergs Arch Pharmacol $x MED00003462
LZP    __
$a Pubmed-20170413

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...